A Patient’s Guide to Zantac

Drugwatch’s experts will help you learn about Zantac (ranitidine), its health risks and how to take legal action if you suffered health problems.

Full Name

Phone Number

We value your privacy. By clicking REVIEW MY CASE, you agree to our privacy policy and disclaimer. After submitting, you will be contacted by one or more of Drugwatch's trusted legal partners (including autodialed and prerecorded calls or text/SMS messages). Msg. and data rates apply. Your consent to text messaging is not required for a case review and you may opt out of text messages at any time by texting STOP. This is legal advertising.

Thank You!

We're looking forward to keeping you up to date on the latest drug and device news. If the PDF failed to download, click here.

Back to Homepage

Zantac Cancer Risks and Recalls

Millions of Americans have taken Zantac or its generic form, ranitidine, for acid reflux or GERD each year since the 1980s. In April 2020, manufacturers withdrew the popular heartburn drug from the U.S. market because of a potential cancer-causing contaminant called NDMA. Drugwatch’s 2022 guide explains how ranitidine products could expose users to unacceptable risks and tells you how to take legal action if you developed cancer after taking Zantac.

Find Out If You Qualify for Compensation

If you or a loved one took Zantac and were diagnosed with cancer, you may be eligible for compensation. In this guide, you’ll learn which cancers are included in lawsuits and what questions a Zantac lawyer may ask.

Take a Look Inside

Zantac Recalls
How Dangerous Is NDMA in Zantac?
Cancer Lawsuits
Am I Eligible to File a Lawsuit?
Questions a Lawyer May Ask
Patient Checklist

Drugwatch is located at:
1 South Orange Ave, Suite 201, Orlando, FL 32801

The information on this website is proprietary and protected. It is not a substitute for advice, diagnosis, treatment and other oversight responsibilities for disease processes by a credentialed physician. Any unauthorized or illegal use, copying or dissemination will be prosecuted. Please read our disclaimer for more information about our website.

Drugwatch.com partners with law firms. This website and its content may qualify as attorney advertising. Prior results do not predict a similar outcome. For more information, visit our partners page.

Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.

If you would like to speak with a Drugwatch representative, please call 888-645-1617